XML 18 R6.htm IDEA: XBRL DOCUMENT v3.24.3
Condensed Consolidated Statements of Shareholders’ Equity (Deficit) (Unaudited) - USD ($)
shares in Millions, $ in Millions
Total
Ordinary Shares and Additional Paid-in Capital
Accumulated Deficit
Accumulated  Other Comprehensive Loss, Net of Tax
Non- redeemable Non- controlling Interests
Beginning balance (in shares) at Dec. 31, 2022   205.4      
Beginning balance at Dec. 31, 2022 $ (429) $ 6,866 $ (2,772) $ (4,623) $ 100
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income 1,079   1,050   29
Shares issued - employee stock compensation plans (in shares)   0.9      
Shares issued - employee stock compensation plans (132) $ (131) (1)    
Shares repurchased (in shares)   (1.8)      
Shares repurchased (550)   (550)    
Share-based compensation expense 127 $ 127      
Dividends to shareholders (115)   (115)    
Net change in fair value of financial instruments 3     3  
Net foreign currency translation adjustments 54     54  
Net postretirement benefit obligation 22     22  
Dividends paid to nonredeemable noncontrolling interests on subsidiary common stock (1)       (1)
Ending balance (in shares) at Mar. 31, 2023   204.5      
Ending balance at Mar. 31, 2023 58 $ 6,862 (2,388) (4,544) 128
Beginning balance (in shares) at Dec. 31, 2022   205.4      
Beginning balance at Dec. 31, 2022 (429) $ 6,866 (2,772) (4,623) 100
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income 2,121        
Net change in fair value of financial instruments 6        
Net foreign currency translation adjustments (29)        
Net postretirement benefit obligation 66        
Ending balance (in shares) at Sep. 30, 2023   200.8      
Ending balance at Sep. 30, 2023 (486) $ 7,017 (3,024) (4,579) 100
Beginning balance (in shares) at Mar. 31, 2023   204.5      
Beginning balance at Mar. 31, 2023 58 $ 6,862 (2,388) (4,544) 128
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income 575   560   15
Shares issued - employee stock compensation plans (in shares)   0.4      
Shares issued - employee stock compensation plans (52) $ (52)      
Shares repurchased (in shares)   (1.7)      
Shares repurchased (550)   (550)    
Share-based compensation expense 99 $ 99      
Dividends to shareholders (127)   (127)    
Net change in fair value of financial instruments 8     8  
Net foreign currency translation adjustments 174     174  
Net postretirement benefit obligation 24     24  
Purchases of subsidiary shares from nonredeemable noncontrolling interests (2) $ (1)     (1)
Dividends paid to nonredeemable noncontrolling interests on subsidiary common stock (45)       (45)
Ending balance (in shares) at Jun. 30, 2023   203.2      
Ending balance at Jun. 30, 2023 162 $ 6,908 (2,505) (4,338) 97
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income 467   456   11
Shares issued - employee stock compensation plans (in shares)   0.2      
Shares issued - employee stock compensation plans 14 $ 14      
Shares repurchased (in shares)   (2.6)      
Shares repurchased (850)   (850)    
Share-based compensation expense 95 $ 95      
Dividends to shareholders (125)   (125)    
Net change in fair value of financial instruments (5)     (5)  
Net foreign currency translation adjustments (257)     (256) (1)
Net postretirement benefit obligation 20     20  
Dividends paid to nonredeemable noncontrolling interests on subsidiary common stock (7)       (7)
Ending balance (in shares) at Sep. 30, 2023   200.8      
Ending balance at Sep. 30, 2023 $ (486) $ 7,017 (3,024) (4,579) 100
Beginning balance (in shares) at Dec. 31, 2023 198.6 198.6      
Beginning balance at Dec. 31, 2023 $ (742) $ 6,946 (3,399) (4,373) 84
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income 1,093   1,071   22
Shares issued - employee stock compensation plans (in shares)   0.8      
Shares issued - employee stock compensation plans (104) $ (104)      
Shares repurchased (in shares)   (0.8)      
Shares repurchased (250)   (250)    
Share-based compensation expense 130 $ 130      
Dividends to shareholders (122)   (122)    
Net change in fair value of financial instruments 75     75  
Net foreign currency translation adjustments (132)     (132)  
Net postretirement benefit obligation 26     26  
Purchases of subsidiary shares from nonredeemable noncontrolling interests (1) $ (1)      
Dividends paid to nonredeemable noncontrolling interests on subsidiary common stock (1)       (1)
Ending balance (in shares) at Mar. 31, 2024   198.6      
Ending balance at Mar. 31, 2024 $ (28) $ 6,971 (2,700) (4,404) 105
Beginning balance (in shares) at Dec. 31, 2023 198.6 198.6      
Beginning balance at Dec. 31, 2023 $ (742) $ 6,946 (3,399) (4,373) 84
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income 1,986        
Net change in fair value of financial instruments 84        
Net foreign currency translation adjustments 129        
Net postretirement benefit obligation $ 39        
Ending balance (in shares) at Sep. 30, 2024 216.5 216.5      
Ending balance at Sep. 30, 2024 $ 6,418 $ 13,047 (2,682) (4,121) 174
Beginning balance (in shares) at Mar. 31, 2024   198.6      
Beginning balance at Mar. 31, 2024 (28) $ 6,971 (2,700) (4,404) 105
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income 536   524   12
Shares issued - NFP Transaction (in shares)   19.0      
Shares issued - NFP Transaction 5,882 $ 5,882      
Shares issued - employee stock compensation plans (in shares)   0.4      
Shares issued - employee stock compensation plans (45) $ (45)      
Shares repurchased (in shares)   (0.8)      
Shares repurchased (250)   (250)    
Share-based compensation expense 117 $ 117      
Dividends to shareholders (148)   (148)    
Net change in fair value of financial instruments 1     1  
Net foreign currency translation adjustments (88)     (88)  
Net postretirement benefit obligation 13     13  
Purchases of subsidiary shares from nonredeemable noncontrolling interests 86       86
Dividends paid to nonredeemable noncontrolling interests on subsidiary common stock (35)       (35)
Adjustments to redeemable noncontrolling interests (13) $ (13)      
Ending balance (in shares) at Jun. 30, 2024   217.2      
Ending balance at Jun. 30, 2024 6,028 $ 12,912 (2,574) (4,478) 168
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income 355        
Net income [1] 354   343   11
Shares issued - employee stock compensation plans (in shares)   0.2      
Shares issued - employee stock compensation plans 20 $ 20      
Shares repurchased (in shares)   (0.9)      
Shares repurchased (304)   (304)    
Share-based compensation expense 114 $ 114      
Dividends to shareholders (147)   (147)    
Net change in fair value of financial instruments 8     8  
Net foreign currency translation adjustments 349     349  
Net postretirement benefit obligation 0        
Purchases of subsidiary shares from nonredeemable noncontrolling interests 1 $ 1      
Dividends paid to nonredeemable noncontrolling interests on subsidiary common stock $ (5)       (5)
Ending balance (in shares) at Sep. 30, 2024 216.5 216.5      
Ending balance at Sep. 30, 2024 $ 6,418 $ 13,047 $ (2,682) $ (4,121) $ 174
[1] The Company’s Net income totaled $355 million for the quarter ended September 30, 2024, which included $1 million of Net income related to redeemable noncontrolling interests.